Japan’s Takeda Plans Friendly Takeover Of Millennium Of U.S.
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceutical, Japan's largest drug maker, plans to acquire Millennium Pharmaceuticals of the United States for $8.8 billion. The friendly merger is expected to give Takeda access to Millennium's oncology drugs such as its Velcade (bortezomib) to treat blood-cancer. Takeda and Millennium said in a joint statement the buy was subject to approval of the U.S. firm's shareholders. (Click here for more